Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
Transplant Immunology|December 27, 2017
Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survivalJusta Friebus-Kardash, Benjamin Wilde, Deniz Keles, et al.Transplantation|October 24, 2014
The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient: The Swiss ExperienceMarc Schiesser, Daniel C Steinemann, Karine Hadaya, et al.Bioscience Reports|March 12, 2020
Low efficacy of vaccination against serogroup B meningococci in patients with atypical hemolytic uremic syndromeNils Mülling, Hana Rohn, Ulrich Vogel, et al.BMC Nephrology|May 16, 2019
Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplantsAnja Gäckler, Sebastian Dolff, Hana Rohn, et al.Vaccines|December 28, 2021
Establishment of an ELISpot Assay to Detect Cellular Immunity against S. pneumoniae in Vaccinated Kidney Transplant RecipientsAnja Gäckler, Nils Mülling, Kim Völk, et al.Radiology|January 9, 2016
Renal Blood Oxygenation Level-dependent Imaging in Longitudinal Follow-up of Donated and Remaining KidneysMaryam Seif, Ute Eisenberger, Tobias Binser, et al.Lancet (London, England)|February 22, 2011
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trialKlemens Budde, Thomas Becker, Wolfgang Arns, et al.Transplantation|March 4, 2021
Norovirus Infections in Kidney Transplant RecipientsAnja Gäckler, Christoph Struve, Nils Mülling, et al.Diagnostics (Basel, Switzerland)|October 16, 2024
Early CYP3A5 Genotype-Based Adjustment of Tacrolimus Dosage Reduces Risk of De Novo Donor-Specific HLA Antibodies and Rejection among CYP3A5-Expressing Renal Transplant PatientsKristina Schönfelder, Birte Möhlendick, Ute Eisenberger, et al.Revue Medicale Suisse|May 16, 2009
[Towards the Swiss systemic lupus erythematosus cohort study (SSCS)]Carlo Chizzolini, Clemens D Cohen, Ute Eisenberger, et al.Pageof 8